explore -WSS

explore

author：focus 2025-09-06 04:41:56 - browse：135

Garry Tan, CEO of Y Combinator Seb Daly/Web Summi

WASHINGTON — In San Francisco, Y Combinator’s firebrand chief executive Garry Tan is one of the startup economy’s most recognizable figures. Well before he became the leader of the coveted startup accelerator that bred global brands like Airbnb, Stripe and OpenAI, Tan was a self-made founder who sold his own company to Twitter.

But here in the nation’s political capital, Tan is far less known. He’s hoping to grow his influence here, offering up his vast network of founders as a source of expertise for regulators struggling to wrap their heads around new technologies like artificial intelligence and how best to rein it in.

“We’re happy to be a phone-a-friend for people who are trying to understand tech,” he told the Economic Club of Washington recently when asked how he’d measure success during Y Combinator’s first-ever policy-focused visit. “‘Little tech’ represents competition, and consumer choice,” he said later at a separate event in a dimly lit Senate room filled with a few dozen Congressional staffers.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

leisure time

hotspot

WSS

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

With competition flaring, obesity drug hits goal in liver disease study

Antivenom research: Lessons from HIV applied in search for universal antidote

Community Health Systems hospitals under DOJ investigation

Medicare inequities exacerbate Puerto Rico’s health disparities

Be careful with at

hotspot

explore

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Heart attack and stroke risk calculators need revising

Aspartame and sugar

Activists slam private health insurers over coverage restrictions

Illumina slashes 2023 revenue projections yet again

Hepatitis C has a cure — but many Americans still lack access to it

R1 RCM gets $5.8 billion buyout offer from private equity firm

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

focus

Schizophrenia gene found to be linked to cells' energy dysfunction

Timeline: How the deadly wildfires took over Maui day by day

Illinois Supreme Court finds assault weapons ban constitutional

Senators push IRS to launch nonprofit hospital probe

Dozens dead from Maui wildfires: What we know about the victims

Surge in Apellis stock fueled by confidence in safety of its eye drug

entertainment

leisure time

hotspot

hotspot